Blocking cancer with RNA interference moves toward the clinic.
Hede
Karyn
K
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D020868:Gene Silencing; D005821:Genetic Techniques; D015316:Genetic Therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics*; D034622:RNA Interference / Q000187:drug effects; D012330:RNA, Double-Stranded / Q000494:pharmacology / Q000627:therapeutic use; D012334:RNA, Neoplasm / Q000187:drug effects; D034741:RNA, Small Interfering / Q000494:pharmacology / Q000627:therapeutic use
D000970:Antineoplastic Agents; D012330:RNA, Double-Stranded; D012334:RNA, Neoplasm; D034741:RNA, Small Interfering